The CapEx vs. OpEx Marketing Model: Why Percentage-of-Spend Pricing Erodes Multi-Site Unit Economics

1. The Percentage-of-Spend Trap

The percentage-of-spend pricing model was designed for a different era — single-location practices, modest local budgets, and marketing campaigns measured in print ads and radio spots. In that context, it made intuitive sense: the agency earns a percentage of what you spend, everyone grows together, and the relationship scales proportionally with the business. Simple. Clean. And structurally misaligned with the realities of a PE-backed multi-site platform managing 50 to 150 locations.

Today, the dominant agency pricing structure charges between 15 and 25 percent of total media spend. For a single-location practice with a $50,000 annual media budget, that translates to $7,500 to $12,500 in agency fees — a tolerable overhead. But when a PE sponsor acquires a dental DSO and scales the media budget from $500,000 to $5 million over a 24-month post-acquisition window, that same percentage model produces a fee structure of $750,000 to $1.25 million annually. The media spend grew 10x. The operational work — managing campaigns, optimizing ad sets, generating reports — grew perhaps 2x. The agency fee grew 10x regardless.

This is not a negotiating problem. It is a structural problem baked into the DNA of the model itself. No individual agency is "taking advantage" of you — they are operating exactly as the incentive structure dictates. The question facing every PE operating partner and portfolio company CMO is whether to continue subsidizing a pricing model that was never designed for platform scale, or to architect a fundamentally different relationship.

The critical insight is this: the percentage-of-spend structure was never calibrated to outcomes. Under this model, fees are earned whether blended cost-per-acquisition improves or deteriorates. Whether CPL is $28 or $280. Whether the platform fills new clinical capacity or wastes media dollars driving traffic to outdated websites with broken booking flows. The model rewards spend, not performance. And at platform scale, the compounding effect of this misalignment is measured not in percentage points, but in enterprise valuation.

Consider what the PE thesis typically assumes at acquisition: a marketing efficiency model that improves as the platform scales — more data, more creative learnings, more geographic concentration of spend, better attribution. What most PE sponsors discover within 12 months of the first add-on acquisition is that marketing costs have followed a linear path rather than the logarithmic curve embedded in the original model. The root cause, almost universally, is a pricing structure built around the wrong economic incentives.

2. Why the Model Breaks at Scale

The percentage-of-spend failure is not a single-point failure. It manifests across three structural dimensions, each one compounding the others. Understanding each failure mode is essential before architecting the alternative.

1. 01
   Linear Cost Scaling

   Agency fees grow proportionally with spend, but the operational work does not. Managing $5 million in Google Ads and Meta campaigns does not require 10x the effort of managing $500,000. Campaign structure, audience segmentation, creative testing — these activities grow modestly with budget. What changes at $5M is the sophistication of the optimization required, not the volume of the work. Yet the percentage-of-spend model bills you as though every additional dollar of media spend requires proportional additional labor. The result: at $5M in annual spend, you are paying a structural premium — essentially a scale tax — that has no relationship to the actual cost of service delivery.

2. 02
   Misaligned Incentives

   The agency is economically incentivized to increase your spend, not your efficiency. This is not a character flaw — it is mathematical reality. If your agency succeeds in reducing your blended CPA by 40% through superior audience targeting and landing page optimization, and they recommend reallocating 30% of your media budget to higher-performing channels, their revenue drops proportionally. The most skilled, most ethical, most high-performing agency under a percentage-of-spend model faces a fundamental conflict between doing excellent work and protecting their revenue stream. The best agencies navigate this conflict through professional integrity. But the structural incentive remains. It creates subtle, unconscious drift toward spend-heavy recommendations and away from the efficiency-first thinking that serves your unit economics.

3. 03
   Zero Infrastructure Compounding

   Each dollar spent with a percentage-of-spend agency is purely OpEx. Nothing compounds. You do not own the proprietary playbooks. You do not own the attribution architecture. You do not own the audience segments that have been refined through 18 months of campaign data. You do not own the institutional knowledge about which creative performs at which stage of the patient acquisition funnel. When the relationship ends — and it will end — you start from zero. Every acquisition you add to the platform, every de novo location you launch, begins without the benefit of accumulated learning. The platform that should be getting cheaper to grow with each passing month instead resets its marketing intelligence with each vendor transition.

The aggregate effect of these three structural failures is predictable and consistent: as the platform grows, the marketing cost structure becomes progressively more burdensome relative to revenue generated. The operator experiences this as "marketing inefficiency" — the vague sense that they are spending more and getting less. What they are actually experiencing is the mathematical consequence of a model that was never designed for compounding scale.

There is also a fourth failure mode that rarely appears in financial models but has significant enterprise value implications: the platform that operates on a percentage-of-spend model is building a business that is, in a meaningful sense, structurally dependent on external vendors. The due diligence buyer — whether a strategic acquirer or a higher-multiple PE sponsor — will identify this dependency during the process and discount accordingly. Marketing infrastructure that lives outside the four walls of the business is a liability, not an asset. It cannot be valued, cannot be defended, and cannot be transferred at exit.

3. The CapEx Alternative

The CapEx marketing model begins with a different fundamental premise: marketing infrastructure is a capital investment, not a recurring expense. Like a CRM system, an EMR platform, or a revenue cycle management architecture, the technology, processes, data structures, and proprietary methods that power patient acquisition represent durable organizational assets that appreciate with use. The question is not whether to spend money on marketing — it is whether that spending builds equity in your organization's infrastructure or simply rents outcomes from vendors.

In practice, the CapEx model manifests across four infrastructure categories that, once built, drive permanent improvements in acquisition economics:

Proprietary Playbook Development

The Strategy Collective Way codifies every campaign launch, market entry, and creative testing protocol into owned intellectual property. When your 40th location opens, the team executing the launch is not starting from first principles — they are deploying a battle-tested, clinically-informed methodology refined across 39 prior launches. The playbook covers market sizing, competitive mapping, initial offer architecture, CPL benchmarks by specialty and geography, escalation protocols for underperforming markets, and the specific creative and messaging frameworks that drive appointment volume in your categories. This institutional knowledge exists inside your organization, not inside your agency's project management software.

Closed-Loop Attribution Architecture

The majority of healthcare platforms operating on percentage-of-spend models have a fundamental attribution gap: they can tell you how many clicks a campaign generated, but they cannot tell you how many of those clicks became booked appointments, kept appointments, or recurring revenue patients. Closing this loop — connecting CallRail or Liine call tracking through the CRM, into the EMR, and back to actual patient lifetime value — transforms the media buying algorithm from a CPL-optimization machine into a clinical revenue engine. The attribution architecture improves with data volume. Every patient acquired, every appointment booked, every revenue cycle event adds signal that makes the next dollar of media more efficient. This is compounding in its most literal form.

Media Buying Algorithms Trained on Clinical Revenue

Platform-level media buying — managing campaigns across 75 or 100 locations — generates an extraordinary amount of performance data. The CapEx model treats this data as an organizational asset, using it to train optimization algorithms on the outcomes that actually matter: not impressions, not clicks, not even CPLs, but actual booked appointments by service line, kept appointment rates by patient acquisition source, and average patient lifetime value by channel. When the algorithm is optimizing toward revenue rather than cost-per-click, the economic outcome for the platform is categorically different. This is only possible when the attribution infrastructure is owned and the data lives in proprietary systems.

Capacity-Aware Media Pods

Perhaps the most operationally distinct element of the CapEx model is the capacity-aware media pod architecture. In the percentage-of-spend model, media spend is allocated based on budget approval — it runs until the budget runs out, regardless of clinical capacity. The capacity-aware pod integrates media spend throttling with real-time scheduling data from the EMR or practice management system. When a location reaches 85% clinical capacity, the pod automatically reduces new patient acquisition spend. When capacity falls below the target threshold due to cancellations or provider additions, the pod increases spend accordingly. This prevents the economically destructive scenario — common in high-growth platforms — where marketing generates appointment volume that the clinical team cannot absorb, flooding the schedule with low-value slots while the valuable ones remain unfilled.

The CapEx model also transforms the organizational posture toward marketing. Rather than a service relationship with a vendor, the platform establishes a strategic partnership with a Digital Operating Partner — a team embedded in the operational cadence of the platform, attending quarterly business reviews, sitting in on clinical capacity planning sessions, and treating marketing infrastructure investment with the same rigor applied to any other capital allocation decision. The language shifts from "campaign performance" to "infrastructure ROI." The metrics shift from "impressions delivered" to "EBITDA contribution per location."

4. Architecting the Transition

Transitioning from a percentage-of-spend model to a CapEx infrastructure model is not a vendor swap — it is an operational transformation that typically unfolds across four phases over 12 to 18 months. Each phase builds on the last, and the sequence matters. Attempting to restructure the agency relationship before the attribution infrastructure is in place, for example, creates a measurement vacuum that makes performance accountability impossible.

1. P1
   Audit: Own vs. Rent Inventory

   Conduct a comprehensive vendor stack audit to categorize every marketing asset and relationship as either "owned" (data, audiences, playbooks, platform accounts) or "rented" (agency-managed assets, vendor-locked reporting, externally-controlled creative libraries). Map every data flow — from ad platform to call tracking to CRM to EMR — and identify every node where the data leaves your control. Quantify the transfer cost of extracting from each rented asset. Most platforms discover that 60 to 80 percent of their marketing intelligence is locked inside vendor systems they do not control. This audit produces the transition roadmap and a clear baseline of the organizational IP gap.

2. P2
   Implement Closed-Loop Attribution

   Deploy the attribution architecture before making any other changes to the agency relationship. This typically involves configuring CallRail or Liine for call tracking at every location, establishing CRM integration so that lead-to-appointment conversion is captured at the individual patient level, and creating the EMR data bridge that connects marketing attribution to actual revenue. The full loop — ad click to revenue — should be operational and validated before proceeding. Average deployment time from legacy vendor extraction to live revenue-attributed media buying is 4.2 months. Do not compress this timeline. A measurement foundation deployed in haste produces attribution data that the team will not trust, and a measurement system without organizational trust is worse than no measurement system at all.

3. P3
   Build Proprietary Media SOPs and Capacity-Aware Throttling

   With attribution in place, begin systematically codifying the platform's acquired campaign knowledge into owned documentation — market entry playbooks, creative testing frameworks, bidding strategy protocols by specialty and market type. Simultaneously, work with the clinical operations team to implement scheduling data integration that will power the capacity-aware throttling system. This phase is the most operationally demanding, requiring close coordination between marketing, clinical operations, and finance. The output is a documented, executable, owned methodology for new patient acquisition — the intellectual property that will drive marketing efficiency for the life of the platform and contribute meaningfully to enterprise value at exit.

4. P4
   Restructure Agency Relationship: Fixed Retainer + Performance Triggers

   With measurement infrastructure in place and proprietary SOPs documented, restructure the agency relationship from percentage-of-spend to a fixed retainer with performance-based incentive triggers. The fixed retainer covers the operational work — campaign management, creative production, reporting, optimization. The performance triggers — bonuses tied to CPA improvement, capacity utilization rates, or EBITDA contribution milestones — align the agency's financial incentives with the outcomes that matter to the platform. This structure eliminates the scale tax, removes the incentive to inflate spend, and creates genuine alignment between agency performance and platform economics. It also provides the predictable cost structure that PE sponsors need for accurate financial modeling through the hold period.

5. The Pro Forma Impact

The financial case for the CapEx transition is most clearly illustrated through a specific platform scenario. Consider a hypothetical 75-location dental DSO — a realistic scale for a mid-market PE platform in the third year post-acquisition — with an annual media budget of $4.5 million and a current agency relationship structured at 18 percent of spend.

In the baseline scenario for the 75-location dental platform, the percentage-of-spend model produces annual agency fees of $810,000 (18% of $4.5M). This figure does not include technology costs, attribution tools, or the internal time spent managing the vendor relationship. Total marketing overhead — agency fees plus attribution and technology costs under the legacy model — is approximately $940,000 annually.

Under the CapEx model, the same platform transitions to a fixed annual retainer of $480,000 for operational management, combined with a performance incentive pool of up to $120,000 triggered by CPA improvement milestones. Total contracted ceiling: $600,000 — a $340,000 reduction in annual marketing overhead, freeing capital for either redeployment into media spend, or direct EBITDA contribution.

The Year 1 results reflect the transition period — infrastructure investment is elevated, CPA improvement is modest as the attribution system is calibrated and the proprietary playbooks are being formalized. The significant improvement occurs in Year 2, when the compounding effect of closed-loop data and capacity-aware spend throttling begins to materialize. The blended CPA drops 37% below the baseline percentage-of-spend model. New patient volume increases by 58% at equivalent media spend. Marketing overhead as a percentage of revenue compresses from 6.8% to 3.3%.

At a platform generating $80M to $120M in annual revenue, the difference between a 6.8% and 3.3% marketing overhead structure represents $2.8M to $4.2M in annual EBITDA that flows directly to the sponsor's return profile. Capitalized at a 10x EBITDA multiple — conservative for a well-run specialty healthcare platform — that infrastructure improvement is worth $28M to $42M in enterprise value. The transition from percentage-of-spend to CapEx is not a marketing initiative. It is a valuation initiative.

6. Implications for PE Sponsors

For private equity sponsors managing healthcare platform investments, the CapEx marketing model has implications that extend well beyond the marketing function. Understanding these implications is essential both for due diligence evaluation and for operating partner work during the hold period.

During Due Diligence

Marketing infrastructure quality is systematically underweighted in healthcare platform due diligence. Financial buyers are expert at evaluating clinical capacity, payer mix, provider compensation models, and reimbursement risk. They are less expert at identifying the marketing stack vulnerabilities that will compress margins and complicate integration post-close. The following questions, asked directly of the target's CMO or agency partners, will surface the key risks:

Red Flags in Agency Contracts

When reviewing agency agreements during due diligence, the following contractual structures should be treated as material risks requiring adjustment in the purchase price or as post-close remediation priorities:

• Ad account ownership clauses that vest ownership in the agency rather than the client. An agency-owned ad account cannot be transferred without losing historical data, performance signals, and Quality Scores — effectively resetting campaign performance to zero upon transition.
• Percentage-of-spend structures exceeding 15% at current spend levels, with no volume discount provisions. At platform scale, this represents a structural margin compression that will be visible in Adjusted EBITDA analysis.
• Reporting structures that do not include conversion-to-revenue attribution. If the agency's performance reporting stops at CPL or cost-per-click, the platform has no financial visibility into marketing ROI — a gap that will produce integration surprises post-close.
• Creative and content ownership clauses that vest creative assets in the agency upon contract termination. Video content, photography, ad creative, and web content produced with company resources should be owned by the company.
• Auto-renewal provisions with short termination windows (less than 90 days notice) that create integration risk if a post-close platform consolidation requires vendor rationalization.

Marketing Infrastructure as an Enterprise Value Driver

The most sophisticated PE sponsors in healthcare services are beginning to treat marketing infrastructure with the same valuation rigor applied to technology platforms. A multi-site healthcare platform with a mature CapEx marketing model — proprietary attribution architecture, owned playbooks, capacity-aware media systems, and a performance-aligned agency relationship — is a fundamentally different asset than an equivalent platform running on a percentage-of-spend agency model. The former has a defensible, scalable, owned system for generating clinical revenue. The latter has a cost structure that will resist margin improvement as the platform scales.

When building the exit narrative, operating partners should explicitly quantify the marketing infrastructure investment and its contribution to EBITDA improvement. The shift from 6.8% to 3.3% marketing overhead as a percentage of revenue is not a rounding error — it is a thesis-validating proof point that the platform's operating model improves with scale. That proof point is worth presenting to the sell-side banker and the prospective acquirer with the same confidence as any other operational improvement.

The era of treating digital marketing as a black-box cost center — something you send money into and hope appointment volume comes out — is ending for the most sophisticated healthcare platforms. The platforms that will command premium multiples at the next cycle of sponsor-to-sponsor sales will be the ones that made the structural decision to treat marketing as infrastructure, not expense. The window to make that structural decision on favorable terms — before scale forces you into emergency vendor transitions — is narrower than most operating partners realize.